Compare IRON & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | EVCM |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2020 | 2021 |
| Metric | IRON | EVCM |
|---|---|---|
| Price | $59.06 | $11.24 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 7 |
| Target Price | ★ $103.18 | $10.67 |
| AVG Volume (30 Days) | ★ 520.9K | 140.2K |
| Earning Date | 05-06-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 145.45 |
| EPS | N/A | ★ 0.10 |
| Revenue | N/A | ★ $588,907,000.00 |
| Revenue This Year | N/A | $7.39 |
| Revenue Next Year | $283.52 | $5.84 |
| P/E Ratio | ★ N/A | $103.90 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $30.82 | $7.66 |
| 52 Week High | $99.50 | $14.41 |
| Indicator | IRON | EVCM |
|---|---|---|
| Relative Strength Index (RSI) | 39.24 | 52.39 |
| Support Level | $57.81 | $10.78 |
| Resistance Level | $64.00 | $12.12 |
| Average True Range (ATR) | 2.81 | 0.74 |
| MACD | 0.08 | -0.08 |
| Stochastic Oscillator | 16.99 | 59.24 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.